Loading organizations...
§ Private Profile · Alexandria, VA, USA
SaaS medication intelligence software for hospitals and pharmacies, optimizing inventory, compliance, and supply chain visibility.
Based in Alexandria, Virginia, Bluesight is a software-as-a-service provider that develops medication intelligence and inventory management solutions for hospital and pharmacy operations. The company's platform utilizes artificial intelligence and RFID tracking to monitor drug diversion, simplify procurement, and ensure regulatory compliance across the entire medication supply chain from manufacturing to the patient. As of 2025, the organization's software is actively deployed across a network of more than 3,000 hospital and health system customers throughout the United States and Canada. Bluesight is backed by lead investor Thoma Bravo, a major private equity firm that provided a strategic growth investment to facilitate the company's ongoing expansion and subsequent acquisitions of healthcare technology firms Medacist and Proten. Originally launched under the name KitCheck, the healthcare technology enterprise was founded in 2011 by co-founders Kevin MacDonald and Tim Kress-Spatz.
Bluesight has raised $37.4M across 3 funding rounds.
Bluesight has raised $37.4M in total across 3 funding rounds.
Bluesight has raised $37.4M across 3 funding rounds. Most recently, it raised $15.0M Series C in June 2016.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 20, 2016 | $15M Series C | Baxter Ventures | Black Granite Capital, Easton Capital, Kaiser Permanente Ventures, LionBird, NEW Leaf Venture Partners, REX Health Ventures, Sands Capital | Announced |
| Jan 12, 2015 | $12M Series B | Dave Schulte | Easton Capital, LionBird, Vijay Lathi, Bobby Helmedag, Sands Capital | Announced |
| Jul 16, 2013 | $10.4M Series A | Vijay Lathi | Easton Capital, LionBird, Sands Capital | Announced |
Bluesight has raised $37.4M in total across 3 funding rounds.
Bluesight's investors include Baxter Ventures, Black Granite Capital, Easton Capital, Kaiser Permanente Ventures, LionBird, New Leaf Venture Partners, Rex Health Ventures, Sands Capital, Dave Schulte, Vijay Lathi, Bobby Helmedag.